Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$0.81 - $3.02
Next Earnings Date
May 12 2025
Next Earnings Date
May 12 2025
Latest price
Market Cap | $48.07M |
EV | $69.54M |
Shares Outstanding | 34.58M |
Beta | 2.88 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $5.00 |
P/E 2025E | - |
P/Revenue 2025E | 5.15x |
Revenue | - |
EPS | 11.20% |
Operating Cash Flow | -19.10% |
Free Cash Flow | 12.50% |
Revenue | - |
EPS | 17.40% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 70.00% |
Net Profit Margin 2025E | -199.75% |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Iterum Therapeutics plc
ITRM
Sector
Healthcare
Industry
Biotechnology
CEO
Fishman, Corey
Employees
9
Website
www.iterumtx.comIPO Date
2018-05-25
Headquarters
Fitzwilliam Court, 1st Floor, Leeson Close, Dublin, Co. Dublin, D02 YW24, Ireland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved